23 Aug 2024 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Member news
22 Aug 2024 A potential new oral drug for leishmaniasis has successfully been tested in healthy humans Member news
15 Aug 2024 SwiftPharma and AntoXa to present plant-made anti-ricin antibody technology to NATO expert panel Member news
08 Aug 2024 When faster is not better: New study links premature development of human neurons to brain developmental disorders Member news
02 Aug 2024 Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools Member news
01 Aug 2024 ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development Member news
29 Jul 2024 Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development Member news
29 Jul 2024 Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
